Clinical Trial Update: Efficacy of a New Nanoemulsion Artificial Tear Targeting Dry Eye Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a nanoemulsion artificial tear for dry eye disease has completed. The study was sponsored by The Hong Kong Polytechnic University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Nanoemulsion artificial tear

Snippet

Sponsor: The Hong Kong Polytechnic University | Conditions: Dry Eye Syndromes | Phase 2 | Status: COMPLETED